United States · 
What does SK Capital Partners invest in?
SK Capital Partners says it invests in Material Sciences, Specialty Ingredients and Life Sciences.
SK Capital Partners highlights
- 01
1 rounds on record
- 02
Sole investor in 1 rounds, median undisclosed
What they do
We are a global private investment firm focused on the material sciences, specialty ingredients, and life sciences sectors, with more than $9B in capital commitments raised since inception.From their own website
- Type
- Private equity
- Cheque size
- Not stated
- Stages
- GrowthBuyout
- Sectors
- Material SciencesSpecialty IngredientsLife Sciences
- Based in
- New York, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first1 appearances
- 2015
1 round
- Jan
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration9 named
ACAaron Charles DavenportDirector, PromoteriFiling they signed
BBBarry Bahram SiadatDirector, PromoteriFiling they signed
JNJack NorrisDirector, PromoteriFiling they signed
JMJames MardenDirector, PromoteriFiling they signed
JVJames Victor GavenChief Compliance Officer/General CounseliForm ADV
JMJamshid Mark KeynejadDirector, PromoteriFiling they signed
JTJerome TruzzolinoChief Financial OfficeriForm ADV
JAJohn A. Norris, Jr.Director, PromoteriFiling they signed
JAJohn Anthony NorrisPartneriForm ADV
We also hold 28 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$8.4Bassets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- SK Capital Partners, LP
- SEC number
- CRD 161487
Funds on its Form ADV
32 private funds, $8.0B in gross assets · filed Mar 2024
- SK Capital Partners V-A, L.P.Private equity79 investors$1.7B
- SK Capital Partners VI-A, L.P.Private equity45 investors$1.5B
- SK Capital Partners IV-A, L.P.Private equity54 investors$987M
- SK Capital Partners V-B, L.P.Private equity41 investors$696M
- SKCP VI Artemis Co-Invest, L.P.Private equity5 investors$642M
- SK Capital Partners VI-B, L.P.Private equity22 investors$627M
- SKCP Catalyst Fund I-A, L.P.Private equity35 investors$316M
- SK Capital Partners IV-B, L.P.Private equity12 investors$219M
- SKCP V Sirona Co-Invest, L.P.Private equity15 investors$187M
- SKCP Catalyst Fund II-A L.P.Private equity36 investors$127M
And 22 more on the filing.
What they claim to have backed
From their own portfolio page (on their website)
3 of 42 we have independently watched raise
EcopolLacertaSwixxbiopharmaAeb-groupArchromaAscendmaterialsAxillonaerospaceBrothersinternationalCanlakDeltechcorpExtractasFlorachemForemarkperformanceGeonHalopharmaHeubachIpackchemIsolatekJkingredientsLuxiumsolutionsMilestone-esNiacetNoramcoNucerasolutionsPerimeter-solutionsPolyventivePptgroupPreceramedicalPurisysSeqensSiigroupSpectraconfectionerySpectrumvascularTechmerpmTilleydistributionTpcgrpUrlValtrisVandemarkVenatorcorpWavelengthpharmaWoodstocksterilesolutions
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Companies it bought
Acquisitions by the firm itself
AEB GlobalUndisclosedMar 2015